ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AMGN Amgen Inc

97.77
0.00 (0.00%)
15:47:20 - Realtime Data
Name Symbol Market Type
Amgen Inc TG:AMGN Tradegate Bond
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 97.77 97.71 97.77 0 15:47:20

Amgen to Present at the Cowen and Company Annual Healthcare Conference

16/03/2009 9:20pm

PR Newswire (US)


Amgen (TG:AMGN)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Amgen Charts.
THOUSAND OAKS, Calif., March 16 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) will present at the Cowen and Company Annual Healthcare Conference on Wednesday, March 18, 2009 at the Boston Marriott Copley Place, Boston, Mass., beginning at 9:30 a.m. Eastern Time. James Daly, Amgen's Senior Vice President of North American Commercial Operations, will present. Live audio of the presentation will be available over the Internet and can be accessed from Amgen's Web site, http://www.amgen.com/, under Investors. Information regarding presentation time, webcast availability, and webcast links are available on Amgen's Investor Relations Events Calendar. About Amgen Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit http://www.amgen.com/. CONTACT: Amgen, Thousand Oaks David Polk, 805-447-4613 (media) John Shutter, 805-447-1060 (investors) (Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO) http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO http://photoarchive.ap.org/ DATASOURCE: Amgen CONTACT: media, David Polk, +1-805-447-4613, or investors, John Shutter, +1-805-447-1060, both of Amgen Web Site: http://www.amgen.com/

Copyright

1 Year Amgen Chart

1 Year Amgen Chart

1 Month Amgen Chart

1 Month Amgen Chart

Your Recent History

Delayed Upgrade Clock